WP
IQMDW

Woodline Partners’s Intelligent Medicine Acquisition Corp. Warrant IQMDW Stock Holding History

Woodline Partners’s Portfolio IQMDW Stock Details IQMDW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-12,500
Closed -$1K – 910
2022
Q3 		$1K Hold
12,500
– – ﹤0.01% 736
2022
Q2 		$2K Hold
12,500
– – ﹤0.01% 785
2022
Q1 		$3K Buy
+12,500
New +$4.56K ﹤0.01% 705

Other funds holding IQMDW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

Woodline Partners's IQMDW Position: Q4 2022 in Review

Woodline Partners sold out of Intelligent Medicine Acquisition Corp. Warrant (IQMDW) in Q4 2022, closing a stake of 12,500 shares — an estimated $1K sold.

Woodline Partners first reported a position in IQMDW in Q1 2022 and held it in 3 quarters. The position peaked at $3K in Q1 2022. 45 funds tracked by Wall St. Rank hold IQMDW as of Q4 2022.

  • Woodline Partners reported no remaining Intelligent Medicine Acquisition Corp. Warrant position as of Q4 2022 after selling out during the quarter.
  • Woodline Partners sold 12,500 Intelligent Medicine Acquisition Corp. Warrant shares in Q4 2022, an estimated $1K.
  • Woodline Partners first reported a position in Intelligent Medicine Acquisition Corp. Warrant in Q1 2022 and held it in 3 quarters.
  • Woodline Partners's Intelligent Medicine Acquisition Corp. Warrant position peaked at $3K in Q1 2022.
  • 45 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Warrant as of Q4 2022.

Based on Woodline Partners's 13F filing for Q4 2022, filed 14 Feb 2023.